UBE2Z
Basic information
Region (hg38): 17:48908407-48929056
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBE2Z gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 0 |
Variants in UBE2Z
This is a list of pathogenic ClinVar variants found in the UBE2Z region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-48908579-G-T | not specified | Uncertain significance (Nov 03, 2023) | ||
17-48908583-T-G | not specified | Uncertain significance (Jun 21, 2022) | ||
17-48908597-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
17-48908609-G-T | not specified | Uncertain significance (Aug 14, 2024) | ||
17-48908646-C-T | not specified | Uncertain significance (Sep 30, 2021) | ||
17-48908667-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
17-48908670-G-C | not specified | Uncertain significance (Apr 19, 2024) | ||
17-48908673-G-C | not specified | Uncertain significance (Apr 24, 2023) | ||
17-48908748-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
17-48910851-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
17-48910866-G-A | not specified | Uncertain significance (Nov 18, 2023) | ||
17-48912837-C-G | not specified | Uncertain significance (Apr 20, 2023) | ||
17-48912894-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
17-48912981-A-G | not specified | Uncertain significance (Feb 09, 2022) | ||
17-48921262-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
17-48922909-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
17-48922935-C-A | not specified | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UBE2Z | protein_coding | protein_coding | ENST00000360943 | 7 | 20688 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.938 | 0.0616 | 125572 | 0 | 2 | 125574 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.87 | 59 | 162 | 0.365 | 0.00000902 | 2303 |
Missense in Polyphen | 14 | 66.992 | 0.20898 | 747 | ||
Synonymous | 0.442 | 55 | 59.3 | 0.927 | 0.00000327 | 708 |
Loss of Function | 3.12 | 1 | 13.2 | 0.0755 | 6.56e-7 | 167 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the covalent attachment of ubiquitin to other proteins (By similarity). Specific substrate for UBA6, not charged with ubiquitin by UBE1. May be involved in apoptosis regulation. {ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:17464193, ECO:0000269|PubMed:17597759}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Post-translational protein modification;protein ubiquitylation;Metabolism of proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Protein ubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.172
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.88
Haploinsufficiency Scores
- pHI
- 0.370
- hipred
- Y
- hipred_score
- 0.523
- ghis
- 0.657
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.496
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Ube2z
- Phenotype
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;apoptotic process;negative regulation of endopeptidase activity;protein ubiquitination;positive regulation of apoptotic process;negative regulation of apoptotic process
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- cysteine-type endopeptidase inhibitor activity;protein binding;ATP binding;ubiquitin conjugating enzyme activity